These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 12860956)
21. Combining molecular therapeutics with radiotherapy for head and neck cancer. Riesterer O; Milas L; Ang KK J Surg Oncol; 2008 Jun; 97(8):708-11. PubMed ID: 18493923 [TBL] [Abstract][Full Text] [Related]
26. Quinoxaline 1,4-dioxides are novel angiogenesis inhibitors that potentiate antitumor effects of ionizing radiation. Gali-Muhtasib H; Sidani M; Geara F; Mona AD; Al-Hmaira J; Haddadin MJ; Zaatari G Int J Oncol; 2004 May; 24(5):1121-31. PubMed ID: 15067333 [TBL] [Abstract][Full Text] [Related]
27. Triple combination of irradiation, chemotherapy (pemetrexed), and VEGFR inhibition (SU5416) in human endothelial and tumor cells. Bischof M; Abdollahi A; Gong P; Stoffregen C; Lipson KE; Debus JU; Weber KJ; Huber PE Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1220-32. PubMed ID: 15519795 [TBL] [Abstract][Full Text] [Related]
28. Targeting multiple signaling pathways as a strategy for managing prostate cancer: multifocal signal modulation therapy. McCarty MF Integr Cancer Ther; 2004 Dec; 3(4):349-80. PubMed ID: 15523106 [TBL] [Abstract][Full Text] [Related]
29. Angiogenesis inhibitors: a rational strategy for radiosensitization in the treatment of non-small-cell lung cancer? Raben D; Helfrich B Clin Lung Cancer; 2004 Jul; 6(1):48-57. PubMed ID: 15310417 [TBL] [Abstract][Full Text] [Related]
30. Small-molecule and antibody approaches to molecular chemotherapy of primary brain tumors. Newton HB Curr Opin Investig Drugs; 2007 Dec; 8(12):1009-21. PubMed ID: 18058572 [TBL] [Abstract][Full Text] [Related]
31. Advances in adenovirus-mediated p53 cancer gene therapy. Tazawa H; Kagawa S; Fujiwara T Expert Opin Biol Ther; 2013 Nov; 13(11):1569-83. PubMed ID: 24107178 [TBL] [Abstract][Full Text] [Related]
32. Vascular-targeting agents and radiation therapy in lung cancer: where do we stand in 2005? Raben D; Ryan A Clin Lung Cancer; 2005 Nov; 7(3):175-9. PubMed ID: 16354311 [TBL] [Abstract][Full Text] [Related]
33. Multiple dietary antioxidants enhance the efficacy of standard and experimental cancer therapies and decrease their toxicity. Prasad KN Integr Cancer Ther; 2004 Dec; 3(4):310-22. PubMed ID: 15523102 [TBL] [Abstract][Full Text] [Related]
34. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth. Gacche RN; Meshram RJ Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944 [TBL] [Abstract][Full Text] [Related]
35. [Angiogenesis and radiotherapy (vessels, anaemia, oxygen and radiosensitivity)]. Lartigau E Bull Cancer; 2007 Jul; 94 Spec No():S197-202. PubMed ID: 17846005 [TBL] [Abstract][Full Text] [Related]
36. Targeted therapy: novel agents against cancer. Tongyoo A J Med Assoc Thai; 2010 Dec; 93 Suppl 7():S311-23. PubMed ID: 21294432 [TBL] [Abstract][Full Text] [Related]
37. Interventions that induce modifications in the tumor microenvironment. Bernhard EJ Cancer Radiother; 2011 Aug; 15(5):376-82. PubMed ID: 21571567 [TBL] [Abstract][Full Text] [Related]
38. Therapeutic targeting of the tumor vasculature. Tozer GM; Bicknell R Semin Radiat Oncol; 2004 Jul; 14(3):222-32. PubMed ID: 15254865 [TBL] [Abstract][Full Text] [Related]
39. Delivery of antiangiogenic agents for cancer gene therapy. Dickson PV; Nathwani AC; Davidoff AM Technol Cancer Res Treat; 2005 Aug; 4(4):331-41. PubMed ID: 16029054 [TBL] [Abstract][Full Text] [Related]
40. Improving tumor response to radiotherapy by targeting angiogenesis signaling pathways. Wachsberger P; Burd R; Dicker AP Hematol Oncol Clin North Am; 2004 Oct; 18(5):1039-57, viii. PubMed ID: 15474334 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]